On the morning of March 10, the fifth session of the 13th National Committee of the Chinese Political Consultative Conference closed in the Great Hall of the People. A total of 5979 proposals were received at the meeting, and after review, 4979 cases were filed, 35 cases were merged, and 965 were converted into opinions and suggestions. Among the proposals filed, 1911 proposals were submitted in the field of economic construction, accounting for 38.4 percent; 499 proposals on political construction, accounting for 10.0 percent; 389 proposals on cultural construction, accounting for 7.8 percent; 1,543 motions on social construction, accounting for 31.0 percent; 613 proposals on ecological civilization construction, accounting for 12.3 percent; and 24 proposals in other aspects, accounting for 0.5 percent.
So in this year's two sessions, which proposals are related to Chinese medicine? Here, Xiaozhen sorted out some proposals on the quality of Chinese medicine, the management of Chinese medicine and the cultivation of Chinese herbal medicines. (↓↓↓ Please swipe up and down to view the following sections)
First, the key words: the quality of traditional Chinese medicine
1 Academician Huang Luqi: The quality of Chinese herbal medicines needs to be standardized
During this year's two sessions, Academician Huang Luqi, member of the Standing Committee of the National Committee of the Chinese People's Political Consultative Conference, deputy director of the State Administration of Traditional Chinese Medicine, and president of the China Academy of Chinese Medical Sciences, submitted <国家中药材质量规范>the "Proposal on Formulation".
"Chinese herbal medicine is the material basis for the prevention and treatment of diseases in traditional Chinese medicine, and is an important raw material for the Traditional Chinese medicine industry such as proprietary Chinese medicine and Chinese medicine tablets. The quality of Chinese herbal medicines is directly related to people's physical health and life safety." Huang Luqi believes that it is necessary and feasible to formulate the National Quality Specification for Chinese Medicinal Materials:
First of all, Chinese herbal medicines come from natural medicinal plants or animals and minerals, and their quality influencing factors mainly include the place of origin, cultivation years, picking time, processing and storage of the place of origin, etc. It is necessary to control the quality of Chinese medicinal materials in accordance with the influencing factors.
Secondly, the Fourth National Census of Chinese Medicine Resources provides first-hand valuable information on the number, resource reserves, and quality of Chinese herbal medicines in mainland China, and accurately depicts the "panorama" of the quality of specific varieties of Chinese herbal medicines.
Third, the Ming Dynasty's "Essentials of Materia Medica" describes 24 cases of each drug by name, seedling, land, time, receipt, use, quality, color, taste, sex, qi, odor, main, line, help, counter, system, treatment, combination, prohibition, generation, taboo, solution, and yi, which fully reflects the quality of Yiwei Chinese herbal medicine. The current national drug standards and local standards for Chinese herbal medicines only focus on index control and lack the quality specifications of the whole process, and the management of the quality of Chinese herbal medicines can be further strengthened by formulating the "National Quality Specifications for Chinese Herbal Medicines".
Fourth, in recent years, the publication of a large number of academic monographs on Chinese herbal medicines, such as the Dictionary of Chinese Medicine Resources and the Standards for Authentic Chinese Medicinal Materials, has laid a solid data and literature foundation for the formulation of the scientific and authoritative National Quality Specifications for Chinese Medicinal Materials. At the same time, it has also trained a group of experts and scholars in the field of Chinese herbal medicines, providing talent support for the formulation of the National Quality Specifications for Chinese Medicinal Materials.
Regarding the preparation route of the "National Quality Specification for Chinese Medicinal Materials", Huang Luqi believes that the State Administration of Traditional Chinese Medicine and the State Food and Drug Administration can jointly organize the national advantageous scientific research resources, integrate experts in Materia Medica, identification, cultivation, processing, etc., and formulate according to the variety in accordance with the links of literature data collection, testing and verification, review, solicitation of opinions, review and release.
The content of the "National Quality Specification for Chinese Medicinal Materials" can be divided into "preparation instructions", "ordinary cases", "variety text", "general principles" and other contents. "Variety body" can be divided into "General Provisions" and "Detailed Rules" according to variety. The "General Provisions" section can contain the contents of the base, medicinal parts, DNA bar codes, road real estate area, cultivation years, harvesting period, etc.; the "Detailed Rules" section can formulate key control parameters or requirements according to the links of germplasm seedlings, cultivation, picking, processing, storage, etc.
Huang Luqi stressed that the "National Quality Specification for Chinese Materia Medica" should be in accordance with the relevant provisions of the "Standardization Law" and the "Drug Administration Law", combined with the practice of quality supervision of Chinese herbal medicines, considering the acceptance of the industry and the practice of law enforcement, it is recommended that most of the contents of the "National Quality Specification for Chinese Materia Medica" be taken as a recommended implementation standard, and a small number of items or provisions should be used as mandatory implementation standards. Specifically, after the detailed plan is formulated and improved, the relevant provisions can be investigated and demonstrated before they can be implemented. The National Quality Specification for Chinese Medicinal Materials is still not a statutory standard, but its influence and effectiveness can be enhanced through the citation of relevant documents, and after the practice is mature, according to the necessity of the implementation process, its position will be consolidated by amending the law or formulating regulations.
He believes that the varieties included in the National Quality Specification for Chinese Medicinal Materials correspond to the specific varieties included in the Chinese Pharmacopoeia (Part I), the standards issued by the ministry and the standards for Chinese medicinal materials promulgated by various provinces, and the contents of the inclusion and the standards for Chinese medicinal materials can complement each other, and the quality control standard system for the whole process of Chinese herbal medicines is constructed.
In addition, the "National Quality Specification for Chinese Materia Medica" focuses on the process control of the quality of Chinese herbal medicines, and the standards for Chinese herbal medicines focus on terminal testing indicators, and the combination of the two can completely control the quality of Chinese herbal medicines, which is conducive to improving the quality of Chinese herbal medicines.
2 Academician Zhang Boli: Improve the quality of Chinese herbal medicines and build a brand
Effect
During the two sessions of the National People's Congress, Zhang Boli, a deputy to the National People's Congress and an academician of the Chinese Academy of Engineering, focused on improving the quality of Chinese herbal medicines, suggested building a regional brand of authentic medicinal materials, promoting the traceability of the whole process of high-quality medicinal materials, and advocating the high quality and high price of Chinese herbal medicines.
Deputy Zhang Boli pointed out that Chinese herbal medicine is an important material basis for the inheritance and innovation of traditional Chinese medicine, and high-quality Chinese herbal medicine is an important material guarantee for the high-quality development of traditional Chinese medicine. In recent years, the demand for Chinese herbal medicines in mainland China has been increasing, and it is necessary to further standardize the order of planting, production and operation, and improve the quality and brand value of Chinese herbal medicines. In his view, although some regions have issued documents to support the development of the local Chinese herbal medicine industry and taken corresponding measures on the breeding of fine seeds, intensive processing, research and promotion of cultivation technology, etc., a national system has not yet been formed, which cannot meet the needs of comprehensively improving the quality and brand value of Chinese herbal medicines.
Combined with the characteristics of the large variety and strong authenticity of Chinese medicinal materials in the mainland and the need to ensure the clinical efficacy of products and promote the sustainable development of the industry, Deputy Zhang Boli suggested exploring the local government monopoly system of authentic medicinal materials, and the provincial (autonomous region, municipal) government is responsible for the monopoly of authentic medicinal materials in the region. He proposed that under the guidance of the relevant state departments, provinces can determine the varieties, quality and grade standards of authentic medicinal materials in their regions, and local governments should coordinate with relevant departments to concentrate on the cultivation of excellent germplasm, and carry out supervision of the whole industrial chain of Chinese medicinal materials from breeding, cultivation, harvesting, processing, warehousing, logistics to sales of fine seeds; local governments issue quality and grading standards for authentic medicinal materials, issue corresponding logos, build regional brands, and support the local Chinese herbal medicine industry.
Deputy Zhang Boli suggested that we should gradually promote the traceability of the whole process of high-quality medicinal materials, carry out the construction of a provincial-level traceability platform for Chinese herbal medicines, promote the standardized management of the whole process of production of Chinese herbal medicines, realize "traceable sources, traceable destinations, and accountable responsibilities", and strengthen quality control.
Deputy Zhang Boli advocated the high quality and high price of Chinese herbal medicines and the priority of high quality, and suggested strengthening departmental coordination, following the market mechanism, encouraging the priority use of high-quality medicinal materials, promoting high-quality and high-priced, and enhancing the market competitiveness of high-quality medicinal materials.
3 Member Zhang Hongchun: Establish a new drug efficacy based on the evidence of traditional Chinese medicine
Evaluation system
The construction of the evaluation system of new Chinese medicines is an important part of the development of traditional Chinese medicine, Zhang Hongchun, member of the National Committee of the Chinese People's Political Consultative Conference, director of the Department of Traditional Chinese Medicine and the Department of Health Care of China-Japan Friendship Hospital, believes that at present, the review and development mode of new Chinese medicine drugs is still accustomed to defining the research and development and registration of new Chinese medicine drugs in accordance with the disease mode of Western medicine and the mode of combining medical evidence, and lacks the corresponding and operable system and guiding principles of new Chinese medicine drugs.
First, in the review and evaluation of new Chinese medicine drugs, it is necessary to further strengthen the national strategic thinking.
The second is to follow the law of traditional Chinese medicine research and development, and formulate and introduce relevant regulatory systems covering the whole process of research and development, review and approval of new Chinese medicine drugs as soon as possible, including review institutions, evaluation standards and implementation rules.
Third, it is imperative to establish an evaluation index system for the efficacy of new Chinese medicines based on the evidence. "Syndrome" is a general term for a series of interrelated symptoms summarized by Chinese medicine, and is the reaction state of the essential organic relationship between the position, etiology, pathogenesis, pathogenesis, and strength of the body's disease resistance at a certain stage in the process of disease. Symptoms are dynamic, complex, and hidden. It is difficult to reflect the efficacy and advantages of "syndrome" in the evaluation of the efficacy of new disease-based Chinese medicine drugs, and it is hoped to do a good job in the relevant supporting technical requirements and implementation.
4 Zhi Gong Dang Central Committee: Shouzheng Innovation accelerates the high quality of traditional Chinese medicine
develop
This year, the Central Committee of the Zhi Gong Dang submitted the "Proposal on Adhering to Integrity and Innovation and Accelerating the High-quality Development of Traditional Chinese Medicine" to the Fifth Session of the 13th National Committee of the Chinese People's Political Consultative Conference.
The "Proposal" pointed out that at present, the development of traditional Chinese medicine in the mainland has made remarkable achievements, but on the whole, it still faces some problems that need to be solved urgently: the Chinese Medicine Law and related policies are difficult to implement continuously; the Chinese medicine system needs to be further improved; the standards of Traditional Chinese medicine need to be further clarified; the quality of Chinese herbal medicines is uneven; the shortage of Chinese medicine talents, the education and inheritance of original thinking in Traditional Chinese medicine are insufficient.
The "Proposal" proposes to implement the Law on Traditional Chinese Medicine and comprehensively promote the high-quality development of traditional Chinese medicine. Improve the supporting laws and policies of the Chinese Medicine Law, strengthen the construction of the Chinese medicine management system, increase the intensity of law enforcement inspections of the Chinese Medicine Law, and promote the solution of existing problems and difficulties. Strengthen the research on the inheritance of the classic essence of traditional Chinese medicine, and improve the pharmaceutical system with Chinese characteristics. Inherit the essence of Traditional Chinese medicine. Improve the service system of traditional Chinese medicine. Give full play to the advantages of traditional Chinese medicine, promote the entry of traditional Chinese medicine medical resources into the grass-roots level, and improve the review and approval mechanism of traditional Chinese medicine. Strengthen the scientific and technological innovation of traditional Chinese medicine and scientifically analyze the principles of traditional Chinese medicine.
5 Member Chen Hongzhuan: Realize the sustainable use of endangered animal medicinal materials
At present, the proportion of endangered species in mainland medicinal animals is about 30%, about 162 species. Due to the long breeding cycle and animal ethics, the protection and replacement of endangered animal medicinal materials is very urgent. To this end, Chen Hongzhuan, a member of the National Committee of the Chinese People's Political Consultative Conference and a professor at Shanghai University of Traditional Chinese Medicine, proposed that multiple measures should be taken at the same time to promote the sustainable development of endangered animal medicinal materials.
He suggested that organized scientific research and multidisciplinary cross-disciplinary collaboration should be carried out to develop artificial alternatives with "consistent chemical composition, equal efficacy, safer and more stable quality". To achieve the sustainable use of endangered medicinal materials is a complex system engineering, involving chemistry, pharmacy, traditional Chinese medicine, biology and other multidisciplinary fields, it is urgent to solve the scientific problems of the research and development of endangered medicinal materials through multidisciplinary cross-integration, effective combination of production, research and management, to solve the scientific problems of the research and development of endangered medicinal materials, breakthroughs in rare Chinese herbal medicine green intelligent manufacturing and bionic synthesis and other key technologies, to provide scientific and technological support for the sustainable development of traditional Chinese medicine.
It is recommended that the relevant departments further strengthen the technical guidance for the registration and declaration of substitutes such as key rare and endangered animal medicinal materials such as bear bile powder, and efficiently promote relevant continuous development and research in accordance with the new registration requirements.
6 Deputy Guo Mei: Construction of a traceability system for the informatization of traditional Chinese medicine
"To promote the high-quality development of traditional Chinese medicine, the quality of traditional Chinese medicine is the foundation, and the improvement of the quality management system of traditional Chinese medicine is the key." At this year's two sessions, Guo Mei, a deputy to the National People's Congress and a professor at the School of Pharmacy of Gansu University of Traditional Chinese Medicine, believes that the construction of the Chinese medicine informatization traceability system is an important tool for establishing and improving the quality management system of Traditional Chinese medicine, promoting the comprehensive management of quality and safety of traditional Chinese medicine, improving the quality of traditional Chinese medicine products, and promoting the improvement of social co-governance capabilities of quality and safety, an important part of the government's performance of regulatory responsibilities, the implementation of the main responsibility of enterprises, and the implementation of the healthy China strategy, and an inevitable requirement for promoting the high-quality development of traditional Chinese medicine.
To this end, she suggested that the Ministry of Commerce, the Ministry of Agriculture and Rural Affairs, the State Food and Drug Administration and other relevant departments further strengthen policy support, strengthen and improve the construction of the Traceability System of Chinese Medicines, introduce support policies for local governments to promote the traceability system of Chinese medicines, effectively solve the problems of large gaps in the construction of traceability informatization, the informatization traceability system built by various departments in the industry is still relatively isolated, and there is no all-round interconnection, so as to lay a more solid foundation for building a perfect and unified Traceability system for Traditional Chinese Medicines in the country.
The State Food and Drug Administration has accelerated the construction of the informatization standard and standard system for the traceability of Chinese medicine tablets and the construction of the traceability system for proprietary Chinese medicines, strengthened policy guidance and support for local construction, effectively opened up the supervision and traceability of the whole process of production, circulation and use, and given greater financial support to the main production areas of Chinese herbal medicines in Gansu and other major Chinese medicine production areas, so that the traceability of the quality of Chinese medicines has become an important component of the quality management system of Chinese medicines, and promote the improvement of the quality of Chinese medicines.
Local governments have better incorporated the traceability of Chinese medicines into the development plan of the Chinese medicine industry, further attached importance to the construction of the informatization traceability system of Chinese medicines, and effectively solved the problems of all-round interconnection and effective traceability supervision of the whole chain.
7 Member Yang Yucheng: Optimize the regional layout of the Chinese herbal medicine seed industry
Chinese herbal medicine seeds are the source of the Chinese medicine industry and the fundamental guarantee for the quality of Chinese herbal medicines and the efficacy of Chinese medicine.
Yang Yucheng, member of the National Committee of the Chinese People's Political Consultative Conference and director of the Agriculture and Rural Affairs Committee of the Hebei Provincial Committee of the Chinese People's Political Consultative Conference, brought a proposal on the top-level design, financial support, and standard system construction of the Chinese herbal medicine seed industry.
"It is necessary to optimize the regional layout of the Chinese herbal medicine seed industry." Yang Yucheng suggested that a special class for the chinese herbal medicine seed industry should be set up to find out the number and scale of Chinese herbal medicine seeds and seedlings in various places and the main body of the seed industry operation market, and establish a big data information database. Relying on the layout of the authentic Chinese herbal medicine industry cluster, we plan the regional development layout of the Chinese herbal medicine seed industry.
Yang Yucheng believes that special funds should be set up to support the development of the Chinese herbal medicine seed industry, especially to support the construction of a large-scale chinese herbal medicine seed and seedling base with a long planting history and a certain scale. Support leading enterprises of Chinese medicinal materials, and give subsidies to large-scale seed and seedling backbone enterprises, large seed industry households, and cooperatives with characteristic agricultural production. For the two major varieties commonly used in bulk and medicinal and food homologous, a number of breeding projects of authentic fine varieties are carefully laid out. Establish a brand with a single variety, and scientifically and reasonably increase high value-added varieties.
He suggested that the system of access to the production and operation of seeds and seedlings should be implemented. Establish systems such as production licenses and business licenses for seeds and seedlings of Chinese medicinal materials, and standardize the threshold for market operation access. Gradually build a standardized quality control system for Chinese herbal medicine seeds, and strengthen the supervision of seed and seedling market transactions.
It is recommended to set up special research and development funds for scientific and technological research, support leading enterprises to cooperate with scientific research institutes, and strengthen source innovation and transformation and promotion of scientific and technological achievements. At the marketing level, seed enterprises can establish brand direct stores; promote the compound development of "e-commerce + store merchants", and provide growers with full-chain services from seeds to seeding, pest control, and medicinal material sales.
8 Representative Wu Xiangjun: Promote the protection and sustainability of endangered Chinese medicinal materials
Continued development
"Chinese herbal medicine is the material foundation for the inheritance and development of traditional Chinese medicine, and it is a strategic resource related to the national economy and people's livelihood, and endangered Chinese herbal medicine resources should be prevented from restricting the high-quality development of traditional Chinese medicine." At the two sessions of the National People's Congress this year, Wu Xiangjun, deputy to the National People's Congress and general manager of Shijiazhuang Yiling Pharmaceutical Co., Ltd., proposed to build a technological innovation platform for artificial breeding of endangered Chinese medicinal materials, accelerate the development and application of endangered Chinese herbal medicines, and establish a long-term mechanism for the protection of endangered Chinese medicinal materials resources to promote the protection and sustainable development of endangered Chinese medicinal materials.
Deputy Wu Xiangjun introduced that at present, some wild Chinese medicinal material resources with wide clinical application are in an endangered state and should be paid enough attention. For example, he said, there are as many as 280 endangered Chinese medicinal materials listed in the Directory of Wild Animals under National Key Protection, the Directory of Wild Plants under National Key Protection, the Red Book of Endangered Animals of China, and restrictions on import and export, and these Chinese medicinal materials play an important role in disease prevention and control.
In his view, the protection and sustainable development of endangered Chinese medicinal materials have achieved certain results, but the challenges cannot be ignored. For example, in the artificial breeding of endangered Chinese medicinal materials, the endangered Chinese medicinal materials with large market demand or the artificial breeding has not been realized, or the input-output ratio of artificial breeding is low, and the artificial breeding technology needs to be broken. Although there are many successful cases in the development of substitutes for endangered medicinal materials, the work related to more varieties has been slow due to the lack of basic research.
In this regard, Deputy Wu Xiangjun suggested that a technological innovation platform for the artificial breeding of endangered Chinese medicinal materials should be built, led by relevant departments, combined with large varieties of traditional Chinese medicine, the screening of endangered Chinese medicinal materials, the formulation of development plans, the establishment of special funds, the guidance of scientific research institutes and universities and enterprises to establish endangered Chinese medicinal materials engineering technology research and development center, and promote the cultivation technology of high-quality seed sources of endangered Chinese medicinal materials and scientific and standardized breeding technology as soon as possible. For endangered Chinese medicinal materials with high clinical value, we should actively seek close-related alternatives with mature artificial breeding technology or rich wild resources, adopt new technologies and new means to accelerate basic research and clinical research, and promote the transformation and utilization of scientific research results.
Deputy Wu Xiangjun called for the establishment of a long-term mechanism for the protection of endangered Chinese medicinal resources. He told reporters that there is a phenomenon of first development and then protection of wild animal and plant resources, and it is necessary to take effective protective measures to avoid the endangerment of Traditional Chinese medicinal materials that are originally rich in resources. He said: "According to the results of the fourth national census of traditional Chinese medicine resources, the sources and richness of Chinese herbal medicine resources can be sorted out hierarchically, and protective measures can be classified for endangered and endangered resources, a dynamic monitoring network can be established, and wild breeding and breeding areas and germplasm resource banks and gene banks can be created, and included in strategic reserve materials." For medicinal resources with endangered trends, intervene in advance and formulate corresponding protection measures. ”
2. Keywords: Management of Chinese medicines
1 Academician Zhang Boli: It is recommended to cancel the "provincial" standard for Chinese medicine formula granules
"In addition to the legal and regulatory nature of any standard, it must also have feasibility, operability and practicality of enterprise production." Reasonable development of standards for traditional Chinese medicine formula granules and granules is the basis for maintaining the healthy and orderly development of the industry. "On March 5, the Fifth Session of the 13th National People's Congress will kick off in Beijing. As the most representative with the most right to speak in the field of traditional Chinese medicine, Zhang Boli, a deputy to the National People's Congress, an academician of the Chinese Academy of Engineering, and the leader of the internal medicine of traditional Chinese medicine in the national key discipline, made suggestions for the "healthy and sustainable development of the Chinese medicine formula granule industry".
In order to promote the modernization and internationalization of Chinese medicine, the standardization and standardization of Chinese medicine formula granules has been included in the implementation of the national strategy. Under the guidance of the State Drug Administration, relevant pilot enterprises in accordance with the requirements of the pilot work, on the basis of inheriting the theory of traditional Chinese medicine, use modern scientific and technological means to innovate the research and development of Traditional Chinese medicine formula granules and realize industrialization. According to the relevant requirements of the Announcement on Ending the Pilot Work of Chinese Medicine Formula Granules jointly issued by the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine and other four departments, from November 1, 2021, Chinese medicine formula granule manufacturers need to produce formula granules in accordance with national and provincial standards.
Subsequently, the State Food and Drug Administration promulgated 196 national standards for Chinese medicine formula granules, and provinces have also successively formulated implementation rules for the management of Chinese medicine formula granules, and successively carried out the release and filing review of provincial standards. However, from the perspective of the implementation of the standard release and filing review of traditional Chinese medicine formula granules in various provinces, the progress of the work is uneven, and there are more than 200 standards announced and released by many provinces, and there are more than 60 few, involving a total of 440 varieties. Some provinces have approved nearly 200 varieties for enterprise filing, while other provinces have only approved a few varieties.
In addition, due to the different standard standards and requirements of the state and provinces, the filing materials need to be studied and reported separately by province, resulting in a huge workload of enterprises and fatigue. According to the investigation and understanding of Deputy Zhang Boli, the current problem mainly exists in four aspects.
First, the progress of formulating national standards for traditional Chinese medicine formula granules is slow and cannot meet the needs of clinical drugs. At present, the State Drug Administration has officially released 196 quality standards for traditional Chinese medicine formula granules, but due to the reasons of cannon products, there are multiple specifications in 196 standards, so the actual variety is only 136 flavors, and there is still a considerable gap from the 400 flavor varieties commonly used in clinical practice, resulting in the lack of varieties when doctors prescribe and cannot meet the needs of clinical drugs.
Second, the national and provincial standards for traditional Chinese medicine formula granules have too high requirements for the standards for the entry of raw medicinal materials and the number of testing indicators for the content of formula granules, resulting in increased production costs and difficult to control quality. For example, the national standard that has been promulgated at present requires far higher than the pharmacopeia standard for the entry of raw materials into the drug, and the number of formula particle content detection indicators is far more than the pharmacopoeia standard, which greatly increases the cost.
Third, the provincial standard formulation requirements for traditional Chinese medicine formula granules are not uniform, and enterprises are tired of coping, resulting in waste of resources. At present, 29 provinces have issued a total of 4326 provincial standards, in addition to duplicate varieties, there are actually 428 varieties. In addition, 75 varieties are in the publicity period, so the overall provincial standard involves 503 varieties. Because the provincial standards for traditional Chinese medicine formula granules are organized and formulated by the drug regulatory departments of various provinces, and the standard requirements of each province are quite different, the standards of the same variety are inconsistent between various provinces, resulting in a chaotic situation of multiple specifications of the same variety.
Fourth, the current implementation of the national standard of "made quantity" as the basis for doctors' prescriptions has hidden dangers and expensive clinical drug safety hazards.
In order to develop the Chinese medicine formula granule industry healthily, reasonably carry out the formulation and filing of standards for Chinese medicine formula granules, and avoid waste of resources and irregular behavior in the market, Representative Zhang Boli put forward four suggestions:
First of all, further increase the formulation of national standards for traditional Chinese medicine formula granules and accelerate the speed of filing, mature a batch, and promulgate a batch. In terms of varieties, give priority to varieties with high clinical use frequency and large amount of use, and strive to use about 1 year to make the standards promulgated by the state reach about 500.
Secondly, rationally formulate the standards for the entry of raw chinese medicine materials into the chinese medicine formula granules and the number of testing indicators for the content of formula granules. Under the premise of maintaining the quality of Chinese medicine formula granules, the standards for the entry of raw medicinal materials and the number of testing indicators for the content of formula granules are reasonably formulated.
Third, cancel the formulation and filing of provincial standards for traditional Chinese medicine formula granules to avoid duplication of research and waste of social resources. Because the provincial standard is only a transitional standard, once the new national standard is promulgated, the original provincial standard will be revoked, which not only increases the unnecessary burden of enterprises, but also causes a great waste of research resources in the early stage. For varieties that have not entered the national standard, the enterprise standards of the six pilot enterprises of traditional Chinese medicine formula granules approved by the State Food and Drug Administration can be temporarily implemented.
Finally, the national standards currently being implemented for "manufactured quantities" as the basis for doctors' prescriptions are reassessed to avoid the safety and cost of medication.
"In order not to change the traditional prescribing habits of Chinese medicine doctors, but also to inherit the culture of traditional Chinese medicine for thousands of years, it is recommended that the State Food and Drug Administration organize relevant departments and experts to discuss and formulate relatively safe quality standards in combination with the actual situation of clinical use of traditional Chinese medicine formula granules for 20 years to ensure the safety and effectiveness of clinical drugs." Representative Chamberlain said so.
2 Academician Zhang Boli: Strengthen research on medicinal and food dual-use items
Standardize management
Medicinal and food dual-use items are a type of article that can be found by human beings in long-term production and life practice that can be eaten as food and can be used as drugs to prevent and treat diseases, and play an important role in the development of human society. Zhang Boli, deputy to the National People's Congress and academician of the Chinese Academy of Engineering, believes that at present, the development of modern science and technology has brought about major changes in people's living environment, living mode, and living standards. The disease spectrum has also undergone tremendous changes, with lifestyle-based diseases becoming major diseases affecting human health.
"The main problems in the development of medicinal and food dual-use items in the mainland are: insufficient attention to medicinal and food dual-use items and lack of cultural self-confidence; the list of medicinal and food dual-use items is too small, which affects the development of related industries; the scientific research on medicinal and food dual-use items is not deep, the investment is low, and it lacks international competitiveness; the relevant laws and regulations are not perfect, restricting the high-quality development of the medicinal and food dual-use goods industry, and adding obstacles to multilateral trade." Chamberlain said.
To this end, Zhang Boli suggested that we should enhance cultural self-confidence, inherit the excellent medicinal food culture and ideological connotation of the motherland, and promote the construction of a healthy China; strengthen investment in scientific research on medicinal and food dual-use items, improve the level of scientific research, and establish more influential brands; clearly list the negative list that cannot be used as medicinal and food dual-use items, and strengthen the investigation and analysis of the literature, clinical and social application of medicinal and food dual-use items. The safety information provided by the specific declaration of medicinal and food dual-use articles shall be comprehensively and systematically evaluated by the expert committee; the relevant laws and regulations of medicinal and food dual-use articles shall be improved, and a management system in line with Chinese characteristics shall be established to promote the dual cycle of domestic and international economies.
3 Member Jiang Jian: Promote more hospital preparations to new drugs of traditional Chinese medicine
invert
"Preparations in Chinese medicine hospitals are one of the source living waters for the research and development of new Chinese medicine drugs, and we should innovate regulatory ideas to promote the transformation of more preparations in Chinese medicine hospitals into new Chinese medicine drugs." At the two sessions of the National People's Congress this year, Jiang Jian, member of the National Committee of the Chinese People's Political Consultative Conference and chief physician of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, paid attention to the research and development of new chinese medicine drugs and brought relevant proposals.
Jiang Jian said that the preparation in the hospital is the characteristic business card of the Chinese medicine hospital and has played a great role in meeting the medical needs of the people. Previously, the number of preparations in traditional Chinese medicine hospitals has declined, and many star hospital preparations have been difficult to find. The reason is nothing more than the high threshold for R&D declaration of new in-hospital preparations, the complicated approval process, and the need to complete pharmacology, toxicology and clinical trials. In 2018, the State Food and Drug Administration issued the Announcement on the Implementation of Filing Management for the Preparation of Traditional Chinese Medicine Preparations by Medical and Health Institutions, which "loosened the binding" for the registration and approval of preparations in Chinese medicine hospitals.
"Clinical data is the key to the study of the efficacy of new Chinese medicine drugs, and attention should be paid to human experience and research should be carried out in multiple ways." In Jiang Jian's view, the state's implementation of simplified approval for the application for listing of ancient classic Chinese medicine compound preparations is an important step in the supervision of traditional Chinese medicine. At the same time, the simplified approval of the classic prescription can also become a sample, providing a reference for the clinical effective experience prescription represented by the preparation in the hospital of Traditional Chinese medicine to the transformation of new drugs of traditional Chinese medicine, and helping the hospital to achieve marketization of the in-hospital preparation of traditional Chinese medicine that has been used clinically for many years and has good efficacy but has not been put into the market.
4 Wang Jie Member: Standardize the management of traditional Chinese medicine preparations in combination with human experience
At this year's two sessions, the development of the traditional Chinese medicine industry is still of great concern, and Wang Jie, member of the National Committee of the Chinese People's Political Consultative Conference and chief researcher of the Chinese Academy of Chinese Medical Sciences, suggested that human experience combined with the latest technology should standardize the management and evaluation of traditional Chinese medicine preparations, explore the new functional indications, populations and doses of existing traditional Chinese medicine preparations, realize the "new use of old drugs", and further enhance the clinical value of existing traditional Chinese medicine preparations.
At present, there are still problems such as low data quality, large internal differences, and many mixed factors in human experience. Therefore, it is necessary to further explore the establishment of chinese medicine preparation management and evaluation standards that conform to the laws of traditional Chinese medicine, so that the empirical data and results of traditional Chinese medicine are more scientific and rigorous, and better guide the research and development of new drugs and the new use of old drugs.
In the management of traditional Chinese medicine, it is necessary to strengthen the quality and safety of tablets and hospital preparations and market regulation functions. Medical institutions need to improve the basic medical related supporting data for their in-hospital preparations, such as the pharmacokinetics of traditional Chinese medicines, clinical trial evidence, drug indications and contraindications. Regulatory departments should appropriately liberalize the autonomy of profit bonuses for in-hospital preparations, fully consider various cost increase factors such as feeding, and promote the industrialization of effective in-hospital preparations.
In terms of talent training, it is recommended to cultivate talents who can inherit the essence of traditional Chinese medicine and have the ability of modern scientific and technological innovation. In order to optimize the existing preparation ratio technology based on the traditional composition law and combined with the innovative group allocation, it is also necessary to cultivate talents who master the new pharmaceutical methods and technologies and have an industrialization vision.
In addition, it is necessary to develop the sustainable development of Chinese herbal medicine resources and explore new ways of green development. Optimize the source structure of Chinese medicine raw materials, explore the active ingredients and mechanisms of action of Chinese medicines, and find possible alternative drugs or resources. Effectively use the results of the fourth national census of traditional Chinese medicine resources, promote the construction of authentic medicinal material bases, and promote the implementation of poverty alleviation actions in the Chinese herbal medicine industry.
5 Member Yue Bingfei: Accelerate the construction of national numbers of traditional Chinese medicine specimens
platform
In the context of the information age, digitizing specimens of natural resources, collecting specimen photos and extracting specimen information have become the basic work of the development of relevant scientific fields in various countries in the world. "Chinese medicine specimens are the basic data of Chinese medicine testing and scientific research, and are still only available in a semi-open form to inspection institutions and experts or scholars in related fields of Traditional Chinese Medicine, and the traditional retrieval and access methods can no longer meet the growing needs of scientific research institutions and the public for the growing information resources of Chinese medicine national medicine specimens." During the two sessions of the National People's Congress this year, Yue Bingfei, a member of the National Committee of the Chinese People's Political Consultative Conference and a researcher at the China Food and Drug Inspection Institute, suggested that the construction of a national digital platform for traditional Chinese medicine specimens should be accelerated.
Member Yue Bingfei introduced that the digitization of the so-called chinese medicine specimens is not only the collection of specimen photos and basic information, but also the digital technical means to excavate the information related to the whole chain of physical specimens and the whole chain of Chinese medicine basal, production, quality and application from multiple dimensions such as morphology, organization, macromolecular compounds and small molecule DNA sequences, and realize the display, sharing and exchange of digital resources through visual, intelligent and networked technical means.
"In the long-term work practice of traditional Chinese medicine supervision, scientific research, teaching, clinical and other fields, a large number of chinese medicine specimens have been accumulated. Compared with natural resource specimens, Chinese medicine specimens have certain particularities. These specimens are an important basis for the registration, inspection, drafting and revision of standards of Chinese medicines, an important reference for scientific research, teaching and science popularization, an archived material for the development and quality control of the development of Chinese medicine industry, and the basis and foundation for the clean source and sustainable development of Chinese medicine. Member Yue Bingfei said that the information covered by Chinese medicine specimens is closely related to the development of the whole industrial chain of Chinese medicine. However, most of the Chinese medicine specimens are biological specimens and are non-renewable, and many meaningful and valuable specimens are wasted and lost to varying degrees due to mold and insects. At the same time, many of the problems encountered by researchers in the drafting, testing and scientific research of Chinese medicine standards need to be compared and studied with accurate specimen information. Based on this, it is urgent to establish a national unified digital platform for Chinese herbal medicine specimens to meet the needs of the innovative development of traditional Chinese medicine heritage.
"It is gratifying that the establishment of a national digital platform for chinese medicine specimens has been proposed in the "14th Five-Year Plan" National Drug Safety and Promotion of High-quality Development Plan released at the end of last year. Member Yue Bingfei suggested that the establishment of a national digital platform for traditional Chinese medicine specimens should do a good job in top-level design, give full play to the advantages of various regions, integrate resources, and study and establish a national digital specimen platform for traditional Chinese medicine and ethnic medicines based on the physical objects of traditional Chinese medicine specimens and with certain professional and social values, so as to provide physical and information support for production, quality control, standard formulation, scientific research, education and science popularization. The construction of the digital platform itself is of a public welfare nature, which requires the relevant departments of the state to set up special funds; at the same time, relying on the construction of the platform, based on the existing collection of specimens, select collaborative units with outstanding characteristics and advantages, and carry out special research on digital specimens for specific varieties; carry out special collaboration and training exchanges, and strengthen the cultivation of talents in the identification and specimen management of traditional Chinese medicines in the drug testing system.
6 Yao Weihai Member: Strengthen the production management of Chinese herbal medicines
"There are more than 500 kinds of medicinal plants artificially planted in the mainland, more than 200 kinds of commonly used bulk Chinese medicinal materials have been planted and cultivated on a large scale, and more than 50 endangered wild Chinese medicinal materials have been planted and cultivated or replaced, which basically meets the needs of the rapid development of clinical drugs of traditional Chinese medicine, traditional Chinese medicine industry and health services." However, in the process of planting and breeding Chinese herbal medicines, there are some problems, which lead to a decline in the quality of Chinese herbal medicines, affect the quality and clinical efficacy of Chinese medicine, and damage the credibility of Chinese medicine." Based on this, at this year's two sessions, Yao Weihai, member of the National Committee of the Chinese People's Political Consultative Conference and director of the emergency department of Beijing Hospital of Traditional Chinese Medicine, submitted a proposal on "Strengthening the Production Management and Quality Improvement of Chinese Herbal Medicines and Promoting the High-quality Development of Traditional Chinese Medicine".
"The cultivation of Chinese herbal medicines involves the responsibilities of agriculture, forestry, industry and information technology, commerce, drug supervision, health, public security and other departments, and all departments are responsible for and do not care about the state, resulting in illegal production of Chinese herbal medicines, quality problems and market chaos", Yao Weihai said, "The gap of Chinese herbal medicines issued by the state is only a technical guiding principle, and lacks specific technical specifications and operating procedures." In addition, the cultivation and processing conditions and technical methods of Chinese herbal medicines are backward, and sometimes even good medicinal materials are processed into inferior medicinal materials and poisonous medicinal materials, which seriously hinders the healthy development of the Chinese medicine industry."
In addition, there is no grade evaluation standard for the quality of traditional Chinese medicines, the quality of medicinal materials is uneven, and the fairness and justice of the market are difficult to reflect, which also affects the healthy development of the industry. In addition, the information is not smooth, the price fluctuations are large, and the situation of individual medicine farmers "planting medicines and hurting farmers" occurs from time to time.
In Yao Weihai's view, to solve the above problems, we need to start from the following five aspects:
First, clarify the main responsibility, the local government of each planting and production area is responsible for the overall responsibility, and the relevant departments cooperate with the linkage management. Promote standardized planting, establish technical specifications of the whole industrial chain and strengthen process control, and jointly supervise and control problems such as adulteration, self-processing of drinking tablets, abuse of plant growth regulators and pesticides, and source treatment, in order to achieve practical results.
Second, strengthen process control to ensure the quality and safety of Chinese herbal medicines. The technical regulations of Chinese medicinal materials from the breeding of fine seeds, seeds and seedlings, planting technology, field management, pest control, pesticide and fertilizer use, harvesting and processing, etc., vary widely among varieties. Formulate production specifications and technical regulations for specific varieties, so that the production process has a law to follow, and ensure that the new Chinese herbal medicine GAP is technically implemented.
Third, focusing on the characteristics of traditional Chinese medicine, with the scientificity, standardization, rationality and feasibility of the standard as the goal, strengthen quality evaluation research, formulate quality grade standards, and gradually improve the quality grading evaluation standard, certification and marking system, so as to lay a good foundation for promoting the high-quality development of the industry.
Fourth, it is recommended to improve the policy design of ensuring high quality and good prices, improve the market mechanism to ensure high-quality development, and strengthen the construction of the quality supervision system. (1) The role of industry associations should be brought into play to ensure quality and reduce vicious price competition; (2) in policy design, attach importance to quality, reasonable price control bidding methods and perfect supporting measures; (3) establish a sound regulatory system, give play to the strength of third-party institutions, information disclosure and public participation.
Fifth, improve the research and development capabilities of modern production technology of traditional Chinese medicine, and promote the coordinated development of traditional Chinese medicine agriculture and traditional Chinese medicine industry. Enhance the development level of traditional Chinese medicine agriculture in seed seedlings, processing industry in the place of origin, ecological breeding, information network construction, etc., support enterprises, colleges and universities, scientific research institutions to establish long-term cooperative relations, cooperate in the development and overcome the basic technology, common technology and key core technology of industrial development, and achieve cluster breakthroughs in key industrial technologies.
7 Member Wu Huangan: Multiple measures to break the price imbalance of Chinese herbal medicines
"For a long time, Chinese medicine therapy has won the love and trust of the people with the characteristics of 'simplicity, convenience, testing and honesty'. Since the implementation of the Law of the People's Republic of China on Traditional Chinese Medicine, the mainland has made remarkable achievements in the work of quality assurance, production supervision and variety protection of traditional Chinese medicine. But correspondingly, the current characteristics of 'low price' of Traditional Chinese medicine are gradually disappearing. Wu Huangan, member of the National Committee of the Chinese People's Political Consultative Conference, deputy director of the Medical and Health Committee of the Shanghai Municipal Committee of the China Association for Promoting Democracy, and professor of Shanghai University of Traditional Chinese Medicine, said frankly that while the price of Chinese herbal medicines has risen, some hospitals, pharmacies and enterprises are facing a state of loss-making operation because they have not yet adjusted the terminal retail price.
"The price increase of Chinese herbal medicines in this round is affected by a variety of factors." Wu Huangan introduced, including: due to the needs of epidemic prevention and control, the consumption of traditional Chinese medicine varieties such as forsythia to treat plague has increased; due to the new version of the Chinese Pharmacopoeia, the quality requirements of traditional Chinese medicine have pushed up the cost of medicinal materials; due to natural disasters such as floods in the central region, as well as the shortage of labor logistics caused by epidemic prevention and control, the supply of some traditional Chinese medicine varieties has been affected. In addition, out of the expectation of rising prices of traditional Chinese medicines, there has also been hoarding and speculation in the market.
"Although the price fluctuations of Chinese herbal medicines are market behaviors, they are also manifested in all aspects of the mainland Chinese herbal medicines from planting to circulation, and the related work is facing some bottlenecks." Wu Huangan said that first, there is a lack of price control mechanism in the field of Chinese herbal medicines. At present, relevant departments are more concerned about the quality of drugs, and there is a lack of monitoring and regulation of prices, and there is a lack of short-term price adjustment means such as import and export control and national reserves. This makes it difficult to curb the short-term sharp fluctuations of Chinese herbal medicines, aggravates the instability of the market, and increases the related costs of traditional Chinese medicine production and storage. Second, the cultivation of Chinese medicinal materials shows the characteristics of "low, small and scattered". The cultivation of Chinese medicinal materials in most parts of the mainland is still in the stage of decentralized and intensive operation of "one household per household", and the agricultural organization model of traditional Chinese medicine such as farms and cooperatives is still in its infancy and exploration. Only some Chinese medicine enterprises have planting bases that meet the norms, the overall mechanization level of Chinese herbal medicine cultivation is low, and the planting and harvesting of Chinese herbal medicines in some areas is greatly affected by labor. The loss of a large number of young and middle-aged labor has caused a decline in the production and quality of medicinal materials, which further affects the price of medicinal materials. Third, the main production areas of Chinese herbal medicines are limited, and the cultivation of Chinese medicinal materials is mainly based on traditional Taoist real estate areas, often limited to one province and one city. When the planting resources of the area are destroyed by factors such as disasters, it will greatly affect the market supply of this variety. For example, in 2021, Henan's exceptionally heavy rains and floods affected the four major Huaiyao production areas, resulting in a decline in the production of related Chinese medicinal materials and an increase in prices. Fourth, the hoarding and speculation in the field of Chinese herbal medicines is relatively low. Chinese medicinal herbs are special agricultural products. Because some varieties have a single origin, the harvest season is concentrated, and the yield is smaller than that of bulk agricultural products such as potatoes, speculators do not have to spend too much money to control the price of a single medicinal material. This has led to some floating funds entering the field of Chinese herbal medicines, speculators hoarding medicinal materials, low in and high out. Some operators have also transformed into "traders" who speculate on Chinese herbal medicines, constantly pushing up the market situation. At present, the mainland has cracked down less on such phenomena, with less intensity, and has not achieved a punitive effect.
To solve the dilemma of rising prices of Chinese herbal medicines, Wu Huangan believes that it should be considered from the following aspects -
First of all, a price detection and adjustment mechanism for Chinese herbal medicines should be established in conjunction with multiple ministries and commissions, and the Ministry of Agriculture and Rural Affairs, the State Drug Administration, the State Administration of Traditional Chinese Medicine, the State Administration of Market Supervision and Administration, the State Grain and Material Reserve Bureau, the General Administration of Customs and other ministries and commissions should jointly study and formulate basic opinions on price monitoring and regulation in the field of Chinese herbal medicines, and improve relevant laws and regulations. Organize relevant departments to design key price monitoring varieties and monitoring indicators in the field of Chinese herbal medicines. Improve the national reserve program for some key medicinal materials. Control the export quota of varieties of Chinese medicinal materials that are in short supply in some markets and have serious price increases, and give priority to supplying them to the domestic market.
Secondly, promote the large-scale and mechanized planting of Chinese herbal medicines, further guide the establishment of large-scale planting bases for Chinese herbal medicines, and promote the business model of Chinese herbal medicine cooperatives at the grass-roots level. Increase the research and promotion of the mechanization of chinese herbal medicine planting, and reduce the decline in the output of Chinese herbal medicines caused by labor loss. Focus on agricultural scientific cooperation on some varieties whose prices rise too fast, increase production on the basis of ensuring the environment in the production area, and ensure market supply.
Third, expand the high-quality emerging production areas of Chinese herbal medicines. As a special type of agricultural product, Chinese herbal medicines can be appropriately introduced across regions under the premise that the soil, water quality and other requirements are met. Under the premise of ensuring the development of the real estate area, we should promote the study of natural characteristics such as soil, water quality and climate in the relevant production areas. Priority will be given to piloting the introduction of species in areas with similar natural resources and low economic level, and to study the consistency of the quality of the introduced medicinal materials. While expanding the production areas of Chinese herbal medicines, it will also help the economic development of underdeveloped areas.
Fourth, focus on cracking down on speculation in the field of Chinese herbal medicines, and while establishing a price monitoring mechanism, introduce relevant rules to combat speculation in the field of Chinese herbal medicines. Cooperate with the market supervision departments of major Chinese herbal medicine markets to collect abnormal market transaction information when the price of Chinese herbal medicines fluctuates, and increase penalties for hoarding, speculation and other behaviors. For a huge number of group speculations, centralized inspection and rectification can be carried out in conjunction with departments such as industry and commerce, taxation, and prices.
8 Du Yan'an representative: improve the promotion of Chinese herbal medicine commodity specifications, etc
Level standard
From breeding to planting, harvesting, processing, storage and sales, Chinese herbal medicines have a long industrial chain, are greatly affected by ecological and environmental factors and are not completely controllable, and are also affected by artificial factors such as planting management and harvesting and processing methods, and are prone to differences in quality and quality due to uneven quality. The specification level of Chinese herbal medicine commodities is an important factor affecting the market price of Chinese herbal medicines, and the unified specification and grading standards of Chinese herbal medicines are of great practical significance to promote the standardized development of Chinese herbal medicine market transactions and guide the high quality and good prices of the Chinese herbal medicine market.
In 2015, the State Council issued the "Development and Development Plan for Chinese Materia Medica (2015-2020)", which clearly proposed to "improve the specification level of commonly used Chinese herbal medicine products"; in 2016, the Chinese Association of Traditional Chinese Medicine issued the "General Rules for the Preparation of Specification And Grade Standards for Chinese Herbal Medicines", and from 2016 to 2018, it issued 226 chinese herbal medicine commodity specification level standards. However, on the basis of complying with the standards of Chinese medicinal materials in the Pharmacopoeia of the People's Republic of China, the specifications and grade standards formulated according to the quality and appearance of Chinese herbal medicines, the nature (binding force) of the standards belongs to the recommended standards, not mandatory standards, and the application in the market is not extensive enough. The survey found that some pharmaceutical manufacturers in Bozhou City do not understand the standard, in practical application, some pharmaceutical manufacturers still use the specification level formed by the market itself, which is generally divided into unified goods and selection, and the specification level of Chinese herbal medicines mainly relies on conventions and experience judgments. In the upstream and downstream industrial chain of Chinese herbal medicines, the pricing mechanism guided by the commodity specifications of Chinese herbal medicines is not perfect. In particular, there is no unified level and quality standards for applications such as medical institutions, and it is difficult to define high quality and difficult to achieve preferential prices. To this end, it is recommended that:
The first is to improve and promote the specification and grading standards of Chinese herbal medicines. On the basis of the existing group standards for the specification level of Chinese herbal medicine commodities, a working mechanism for the research and formulation of standards for the specifications and standards of Chinese herbal medicines with enterprises as the main body and the associations and scientific research institutes as the technical support is established, so as to improve the scientific and practical nature of the standards and continuously improve the specifications and grade standards of high-quality Chinese medicinal materials.
The second is to explore the connection and linkage mechanism between the specification level of Chinese herbal medicines and the upstream and downstream production and application links of Chinese herbal medicines. Taking the specification and grading standards of Chinese herbal medicines as the starting point, we will explore the connection and linkage of high-quality standards in the upstream and downstream links of Chinese herbal medicines, promote the high quality and good price of Chinese herbal medicine products, and promote the quality improvement of Chinese medicine products and the high-quality development of the Chinese medicine industry.
3. Keywords: cultivation of Chinese medicinal materials
1 Deputy Liu Qingmin: Support the development of chinese herbal medicine planting in rural areas
How to use the cultivation of Chinese medicinal materials to achieve rural revitalization has always been a topic of concern to Liu Qingmin, a deputy to the National People's Congress and a village doctor in KumaQuan Village, Miaoguan Town, Surabaya County, Shandong Province. At this year's two sessions, Liu Qingmin brought the "Proposal on Effectively Strengthening the Construction of Chinese Herbal Medicine Bases and Promoting Rural Revitalization", and he proposed that the development of the rural Chinese herbal medicine planting industry should be vigorously supported.
Liu Qingmin suggested that it is necessary to persist in highlighting characteristics and implement them in different categories. According to the rural natural environment and market economy conditions, the development model is reasonably selected, such as the forest medicine seeding model. According to local conditions, rational arrangements should be made for the planting of Chinese medicinal materials such as honeysuckle, windproof, and dried, and the planting should be promoted in rural areas across the country. It is necessary to adhere to policy support, formulate and improve various policies, and support the economic development of the forest in terms of projects and funding arrangements to ensure that farmers get benefits. The State Administration of Traditional Chinese Medicine and other departments should increase investment and follow up the supervision and guidance of the demonstration base of Chinese herbal medicines. It is necessary to persist in mechanism innovation. Do a good job in the forest fruit set of Chinese herbal medicine base project, with a point to lead the face, improve the enthusiasm of farmers in planting Chinese medicinal materials, a large area of development of the forest Chinese herbal medicine seeding model, and strive to build the base into a modern ecological tourism, tourism mountaineering, Traditional Chinese medicine fruit and vegetable picking and other agricultural science and technology to benefit farmers, rural culture as one of the modern new rural Chinese medicine seed base.
2 Li Hongliang representative: Leading enterprises to promote the cultivation of Chinese herbal medicines
industry development
At the "deputies' channel" of this year's two sessions of the National People's Congress, Li Hongliang, deputy to the National People's Congress and deputy secretary of the party committee and mayor of Xinhe Town, Chaisang District, Jiujiang, Jiangxi Province, introduced the rural revitalization picture of "thousands of mu of tea, thousand mu of oil tea, thousand mu of lotus root, thousand mu of Chinese medicinal materials, and thousand mu of shrimp and rice" in Xinhe Town, once again showing the role of traditional Chinese medicine as an economic resource with great potential in economic and social development.
Li Hongliang introduced that in recent years, Xinhe Town has developed the planting of hawthorn, honeysuckle and other Chinese medicinal materials planting industry, of which the honeysuckle planting area exceeds 3,000 mu, and the largest single planting area reaches 2,000 mu, which has effectively promoted the development of the local industry. However, in the early stage of development, the problems of "small and weak" industry, low enthusiasm for planting by farmers, and poor sales channels often make some places "taste shallow and stop".
"To solve the above problems, it is necessary to cultivate or introduce leading enterprises and give play to the leading role of leading enterprises." Li Hongliang said that compared with small planting cooperatives, small enterprises and retail households, leading enterprises have the characteristics of stable sales, strong anti-risk ability and high market acumen, which can help realize the extension of the industrial chain and effectively drive small planting cooperatives, small enterprises or retail households to plant. In practice, many places have explored the model of "government + enterprise + cooperative + farmer", the government combines land, financial tools, technical resources and other aspects, enterprises or planting cooperatives hire local villagers to engage in seedlings, fertilization, weeding and other work, to solve the problem of villagers in the vicinity of employment, while increasing the income of villagers at the same time to increase the village collective economic income, is a very successful exploration model.
3 Deputy Xiong Weizheng: It is necessary to increase subsidies for the cultivation of Chinese medicinal materials
At this year's two sessions, Xiong Weizheng, a deputy to the National People's Congress and founder of Lingrui Pharmaceutical, submitted a proposal on increasing special subsidies for the planting industry of Chinese herbal medicines.
Xiong Weizheng said that the medicinal effect of traditional Chinese medicine is inseparable from the authenticity of raw materials for Chinese herbal medicines. Pharmaceutical companies pursue the use of authentic medicinal materials because their important ingredient content meets the standards noted in the Chinese Pharmacopoeia, which is the basis for achieving high-quality Chinese herbal medicines. However, the protection and production management of authentic medicinal material resources is the key, and it is necessary to plan and guide the construction of authentic medicinal materials production bases, promote standardized and standardized production, and steadily improve the quality of Chinese herbal medicines.
"However, with the rapid development of the Chinese herbal medicine industry, the problems restricting the development of the industry such as low planting standards, small enterprise scale, and few professional talents have gradually emerged, and the mainland's subsidies for the cultivation of Chinese herbal medicines are still relatively small, and there is still a gap in the overall layout and standardization of the industry," Xiong Weizheng said.
Based on this, Xiong Weizheng suggested:
First, establish a budget for special funds. Through the establishment of scientific research units responsible for seedling breeding technology research, leading enterprises responsible for large-scale breeding and promotion of high-quality seedlings, and technical guidance for planting farmers, the quality of Chinese herbal medicine raw materials is guaranteed. In addition, it is necessary to introduce specific policies to replace awards with compensation, increase special subsidies for leading enterprises, and support them to promote the development of the Chinese herbal medicine planting industry.
Second, set up a risk fund for Chinese herbal medicines. Professional cooperatives, family farms and growers will all be included in the insurance coverage, so as to improve the ability of growers to resist risks, and give planting subsidies to increase the enthusiasm of growers. Through support subsidies, the cost of planting Chinese medicinal materials will be reduced, the large-scale planting of Chinese medicinal materials will be realized, and the planting area of Chinese medicinal materials will be stabilized, so as to greatly increase the output of Chinese medicinal materials, maximize the income of "medicine farmers", and improve the uneven quality of authentic medicinal materials.
Content source: Rare herbs